TRIM21 and cancer: Nevertheless, the presence of anti-Ro52, together with anti-U1 RNP or anti-Th/To autoantibodies, was reported to be associated with a decreased risk of cancer when compared with the presence of anti-Ro52 autoantibodies alone [30].